Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 13, 2009

Premium

MDRNA has appointed James Karis to its board of directors.

Karis previously served as president and CEO of life sciences firm Entelos. Before that, he held positions with various contract research firms, most recently COO of Parexel and Pharmaco.

He has a BS in management and economics from Purdue University, as well as a masters in applied economics from The American University.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.